Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transfusion-transmitted disease

C A Lee1

  • 1Haemophilia Centre & Haemostasis Unit, Royal Free Hospital NHS Trust, Hampstead, London, UK.

Bailliere'S Clinical Haematology
|June 1, 1996
PubMed
Summary
This summary is machine-generated.

Patients with haemophilia often contracted viral infections, including HIV and hepatitis, from blood products before 1985. While transmission has decreased, managing these viral complications remains a significant clinical challenge.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Measurement of colour flow using jet-pull observables in <math></math> events with the ATLAS experiment at <math> </math>.

The European physical journal. C, Particles and fields·2019
Same author

Performance of missing transverse momentum reconstruction with the ATLAS detector using proton-proton collisions at <math> </math>.

The European physical journal. C, Particles and fields·2019
Same author

Operation and performance of the ATLAS Tile Calorimeter in Run 1.

The European physical journal. C, Particles and fields·2019
Same author

Search for electroweak production of supersymmetric particles in final states with two or three leptons at <math> </math> with the ATLAS detector.

The European physical journal. C, Particles and fields·2019
Same author

Measurement of the azimuthal anisotropy of charged particles produced in <math> </math> = 5.02 TeV Pb+Pb collisions with the ATLAS detector.

The European physical journal. C, Particles and fields·2019
Same author

Search for Higgs boson pair production in the <math></math> channel using <math></math> collision data recorded at <math></math> <math></math> TeV with the ATLAS detector.

The European physical journal. C, Particles and fields·2019
Same journal

Current status of stem cell therapy and prospects for gene therapy for the disorders of globin synthesis.

Bailliere's clinical haematology·2000
Same journal

Pharmacological therapy.

Bailliere's clinical haematology·2000
Same journal

Prenatal diagnosis and screening of the haemoglobinopathies.

Bailliere's clinical haematology·2000
Same journal

Sickle cell disease: clinical management.

Bailliere's clinical haematology·2000
Same journal

Pathophysiology of sickle cell disease.

Bailliere's clinical haematology·2000
Same journal

Thalassaemia: clinical management.

Bailliere's clinical haematology·2000
See all related articles

Area of Science:

  • Hematology
  • Virology
  • Public Health

Background:

  • Haemophilia patients historically received blood products, increasing vulnerability to viral infections.
  • Significant viral infections, including HIV and hepatitis (HAV, HBV, HCV), have been documented in haemophilia patients.
  • Pre-1985 clotting factor concentrates posed a high risk for viral transmission.

Purpose of the Study:

  • To review the spectrum of viral infections in haemophilia patients.
  • To discuss the impact of viral infections on haemophilia management and patient outcomes.
  • To highlight the evolution of viral transmission risks and current challenges.

Main Methods:

  • Literature review of viral infections in haemophilia.
  • Analysis of historical and current data on transfusion-associated viral diseases.

Related Experiment Videos

  • Discussion of clinical management strategies for viral infections in haemophilia.

    • Main Results:

    • HIV infection significantly reduced life expectancy in haemophilic patients, with no new cases since 1986.
    • Transfusion-associated hepatitis (HAV, HBV, HCV) is a major complication; vaccination for HAV and HBV is recommended.
    • HCV infection was prevalent in patients treated before 1985; treatment strategies are evolving.
    • Parvovirus and other emerging viruses (GBV-A, B, C, HGV) can be transmitted via clotting factors.
    • Concerns exist regarding potential transmission of CJD through blood products, though no direct link to haemophilia is established.

    Conclusions:

    • Viral infections remain a critical concern for haemophilia patients, impacting morbidity and mortality.
    • Improved screening and treatment protocols have reduced but not eliminated viral transmission risks.
    • Ongoing vigilance and research are necessary for effective management of viral co-infections in haemophilia.